StockDrifts LogoStockDrifts

Seorin Bio 038070

Company
서린바이오Seorin Bio
Insiders
1
Buys
1
Total Value
₩14M ($10K)
Avg Return
-1.11%
Last Filing
2026-03-26

Seorin Bio (038070) has 1 disclosed insider purchases and 0 disclosed disposals on record, filed by 1 distinct insiders. Together those filings cover ₩14M ($10K) in reported transaction value. The earliest filing StockDrifts holds for Seorin Bio is dated 2024-03-28; the most recent is 2026-03-26. Across these filings the average return since disclosure is -1.11%, measured from each filing date to the latest available close.

Price & insider activity (12 months)

Recent insider trades

DateTypeSourceInsiderPositionSharesPrice at filingReturnValue
2026-03-26BUY주식배당
안광기
An Gwang-gi
Full-time auditor49₩6,260+2.2%₩307K ($213)
2026-03-26BUY주식배당
강미옥
Kang Mi-ok
CEO/President203₩6,260+2.2%₩1M ($882)
2026-03-26BUY주식배당
황을문
Hwang Eulmun
CEO/Chairman57.7K₩6,260+2.2%₩361M ($251K)
2026-02-03BUYMarket Buy
강미옥
Kang Mi-ok
CEO/President2.3K₩6,290-1.1%₩14M ($10K)
2025-03-26BUY주식배당
황을문
Hwang Eulmun
CEO/Chairman57.7K₩7,001-11.2%₩404M ($280K)
2025-03-26BUY주식배당
강미옥
Kang Mi-ok
CEO/President203₩7,001-11.2%₩1M ($987)
2025-03-26BUY주식배당
안광기
An Gwang-gi
Full-time auditor49₩7,001-11.2%₩343K ($238)
2024-03-28BUY주식배당
강미옥
Kang Mi-ok
CEO/President200₩9,550-34.9%₩2M ($1K)
2024-03-28BUY주식배당
안광기
An Gwang-gi
Full-time auditor48₩9,550-34.9%₩458K ($318)
2024-03-28BUY주식배당
황을문
Hwang Eulmun
CEO/Chairman56.8K₩9,550-34.9%₩543M ($377K)

Frequently asked questions

Who has been buying Seorin Bio stock?
1 distinct insiders have filed 1 disclosed insider purchases in Seorin Bio (038070), most recently on 2026-03-26. Each filer, their role, the number of shares and the price at filing are listed in the table on this page.
How many insider filings does Seorin Bio have?
Seorin Bio has 1 buy-side and 0 sell-side disclosures on record, covering ₩14M ($10K) in total reported value, spanning 2024-03-28 to 2026-03-26.
Do insider buys in Korean stocks predict returns?
Not uniformly. StockDrifts analysed 170,720 share-count changes across 56,930 Korean regulatory filings using cross-sectional alpha at fixed forward horizons, and found returns concentrated in particular signal tiers rather than in insider buying generally.

More on this data

Every trade listed above comes from an official regulatory disclosure. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.